A worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 60 independent distributors into over 100 countries.
Type
Public
HQ
Mountain View, US
Founded
1989
Size (employees)
108 (est)
Website
iridex.com
IRIDEX was founded in 1989 and is headquartered in Mountain View, US

IRIDEX Office Locations

IRIDEX has an office in Mountain View
Mountain View, US (HQ)
1212 Terra Bella Ave

IRIDEX Data and Metrics

IRIDEX Financial Metrics

IRIDEX's revenue was reported to be $46.2 m in FY, 2016 which is a 11% increase from the previous period.
$, USD

Revenue (FY, 2016)

46.2 m

Revenue growth (FY, 2015 - FY, 2016), %

11%

Gross profit (FY, 2016)

20.8 m

Gross profit margin (FY, 2016), %

45%

Net income (FY, 2016)

(11.7 m)

EBIT (FY, 2016)

(2.6 m)

Market capitalization (23-Jun-2017)

104.4 m

Closing share price (23-Jun-2017)

9.1

Cash (31-Dec-2016)

23.7 m
IRIDEX's current market capitalization is $104.4 m.
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

38.3 m42.8 m41.8 m46.2 m

Revenue growth, %

12%(2%)11%

Cost of goods sold

19.7 m21.4 m21.8 m25.3 m

Gross profit

18.6 m21.4 m20 m20.8 m

Gross profit Margin, %

49%50%48%45%

Sales and marketing expense

7.7 m8.2 m8.9 m10.3 m

R&D expense

3.7 m4.6 m5.2 m5.4 m

General and administrative expense

5 m6 m5.6 m7.6 m

Operating expense total

16 m18.8 m19.7 m23.4 m

EBIT

288 k(2.6 m)

EBIT margin, %

1%(6%)

Income tax expense

31 k(8.7 m)(183 k)9.1 m

Net Income

2.2 m10 m474 k(11.7 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

13.4 m13.3 m10 m23.7 m

Inventories

10.6 m9.1 m11.1 m11.6 m

Current Assets

32 m32.9 m30.8 m45.9 m

PP&E

543 k735 k1.1 m1.5 m

Goodwill

533 k533 k533 k533 k

Total Assets

33.7 m41.8 m41.8 m48.1 m

Accounts Payable

2.3 m1.8 m2.2 m2 m

Current Liabilities

7.4 m7 m7.4 m8.5 m

Additional Paid-in Capital

40.7 m38.5 m38 m55.2 m

Retained Earnings

(14.9 m)(4.9 m)(4.4 m)(16.1 m)

Total Equity

33.7 m39.2 m

Financial Leverage

1.2 x1.2 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.2 m10 m474 k(11.7 m)

Depreciation and Amortization

490 k420 k522 k648 k

Accounts Receivable

(1.9 m)(1.1 m)(1 m)(865 k)

Inventories

(2.5 m)1.5 m(2 m)(537 k)

Accounts Payable

173 k(520 k)465 k(229 k)

Cash From Operating Activities

767 k4 m(593 k)

Purchases of PP&E

(380 k)(568 k)(875 k)(1.1 m)

Cash From Investing Activities

(763 k)(1 m)(1.3 m)(1.5 m)

Cash From Financing Activities

1 m(3.1 m)(1.4 m)15.4 m

Income Taxes Paid

(536 k)35 k27 k22 k
$, USDY, 2016

Revenue/Employee

427.4 k

Financial Leverage

1.2 x

IRIDEX Market Value History

IRIDEX Online and Social Media Presence

IRIDEX Company Life and Culture

You may also be interested in